Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8183533 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2SUCNR1GAAALDH1A1PRKCA | |
| SCHEMBL2807289 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2SUCNR1GAAALDH1A1PRKCA | |
| SCHEMBL14867340 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2SUCNR1GAAALDH1A1PRKCA | |
| SCHEMBL6252053 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2SUCNR1GAAALDH1A1PRKCA | |
| SCHEMBL19788605 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2SUCNR1GAAALDH1A1PRKCA | |
| SCHEMBL8039345 | 0.85 | SMN1; SMN2 (0.38) | SMN1; SMN2GAAALDH1A1PRKCAKDM4E | |
| SCHEMBL8040037 | 0.85 | SMN1; SMN2 (0.38) | SMN1; SMN2GAAALDH1A1PRKCAKDM4E | |
| SCHEMBL8050829 | 0.85 | SMN1; SMN2 (0.38) | SMN1; SMN2GAAALDH1A1PRKCAKDM4E | |
| SCHEMBL7907083 | 0.81 | USP2 (0.38) | SMN1; SMN2GAAALDH1A1PRKCAKDM4E | |
| SCHEMBL7904533 | 0.81 | USP2 (0.38) | SMN1; SMN2GAAALDH1A1PRKCAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0856315-B1 | PROTEIN-FARNESYLTRANSFERASE INHIBITORS IN COMBINATION WITH HMGCOA-REDUCTASE-INHIBITORS FOR THE TREATMENT OF AIDS | BANYU PHARMA CO LTD (JP) | 2005-08-24 | — | — | EP | disclosed |
| US-6083985-A | LOVASTATIN, SIMVASTATIN, PRAVASTATIN OR FLUVASTATIN OR DERIVATIVES DECREASES FARNESYL PYROPHOSPHATE IN VIVO; PROTEIN-FARNESYLTRANSFERASE INHIBITOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
| EP-0776884-B1 | SUBSTITUTED AMIDE DERIVATIVE | BANYU PHARMA CO LTD (JP) | 2000-01-05 | — | — | EP | disclosed |
| EP-0856315-A1 | MEDICINAL COMPOSITION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-08-05 | — | — | EP | disclosed |
| EP-0836383-A1 | COMBINATIONS OF INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 1998-04-22 | — | — | EP | disclosed |
| US-5643958-A | ANTITUMOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0776884-A1 | SUBSTITUTED AMIDE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
| WO-1997001275-A1 | COMBINATIONS OF INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1997-01-16 | — | — | WO | disclosed |